Skip to main content
. 2011 May 8;2011:469127. doi: 10.1155/2011/469127

Figure 1.

Figure 1

A flow diagram describing the cohort with virological breakthrough (>1000 copies/mL) as a subset of ART-naïve adults commencing treatment at the HCTC and subsequent outcomes.